Biodesix, Inc. logo — Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 &...

Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner

Founded 2006 United States Louisville, United States 356 employees Post-IPO Equity Total: $312.49M Biotechnology, Health Care

General Information

Company Name Biodesix, Inc.
Founded Year 2006
Location United States Louisville, United States
Founders / Decision Makers
Team member Team member
Employees 356
Industries Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Biodesix, Inc.. To contact Biodesix, Inc., visit biodesix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biodesix, Inc. compare?

A PDF of Biodesix, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biodesix, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Biodesix, Inc.

Biodesix, Inc. is a leading diagnostic solutions company in the realms of biotechnology and health care. Since its founding in 2005, the company has firmly established itself as a leader in diagnostic solutions, offering a range of Medicare-covered tests for lung cancer within the oncology healthcare continuum. Their portfolio of patented technologies, science, and processes has positioned them as a key player in the industry, making them an attractive partner for Biopharma companies. Their expertise spans across areas such as proteomics, genomics, liquid biopsy, and more, indicating their commitment to advanced and innovative practices. In April 2024, Biodesix, Inc. received a notable $55.00M Post-IPO Equity investment, showcasing a strong market interest in the company's endeavors. As a United States-based company, Biodesix, Inc. continues to make significant strides in the fields of biopharma, biotech, and lifesciences.

Business keywords: diagnostic solutions, lung cancer, oncology, biopharma services, proteomics, genomics, liquid biopsy, biotech, lifesciences, molecular diagnostics, companion diagnostics, mass spectrometry analysis, biomarkers, clinical trials, multi-omics

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $55.00M -
05 Apr 2024
Post IPO Debt $50.00M 1
Perceptive Advisors
16 Nov 2022
Post IPO Equity $11.70M -
07 Apr 2022
Post IPO Equity $50.00M 1
Lincoln Park Capital Fund
07 Mar 2022
Venture Round $20.90M -
01 Oct 2020
Venture Round $17.51M -
10 Oct 2018
Venture Round $5.28M -
10 May 2018
Series F $22.00M -
26 Feb 2016
Series E $11.00M -
23 Jun 2015
Series E $12.00M -
12 Jan 2015

View All 15 Funding Rounds

Biodesix, Inc. Alternatives & Competitors

View All Alternatives
Biodesix, Inc. vs
PrognomiQ Inc
PrognomiQ Inc United States

Transform healthcare and early disease detection through the power of multi-omics data.

44 employees
Biopharma, Biotechnology
Biodesix, Inc. vs

The Future of Cancer Diagnostics

Series A
24 employees
Biotechnology, Health Care
Biodesix, Inc. vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post-IPO Equity
49 employees
Biotechnology, Health Care

FAQ About Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner
Biodesix, Inc. was founded in 2006.
Biodesix, Inc. is headquartered in Louisville, United States.
Biodesix, Inc. operates in Biotechnology and Health Care. Its work centres on diagnostic solutions, lung cancer, oncology and biopharma services.
Biodesix, Inc. has approximately 356 employees.
Biodesix, Inc. has completed 15 funding rounds, raising a total of $312.49M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Biodesix, Inc. include PrognomiQ Inc, Dxcover, Biocept, Inc. , Diatech Pharmacogenetics, Elphogene, s.r.o.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biodesix, Inc. and PrognomiQ Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biodesix, Inc., https://bouncewatch.com/company/biodesix-inc, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes